ENGINEERED PRIMATE L-METHIONINASE FOR THERAPEUTIC PURPOSES
    4.
    发明申请
    ENGINEERED PRIMATE L-METHIONINASE FOR THERAPEUTIC PURPOSES 有权
    用于治疗用途的工程化的主要L-甲硫氨酸酶

    公开(公告)号:US20170044514A1

    公开(公告)日:2017-02-16

    申请号:US15297102

    申请日:2016-10-18

    IPC分类号: C12N9/88

    摘要: Methods and compositions relating to the engineering of an improved protein with methionine-γ-lyase enzyme activity are described. For example, in certain aspects there may be disclosed a modified cystathionine-γ-lyase (CGL) comprising one or more amino acid substitutions and capable of degrading methionine. Furthermore, certain aspects of the invention provide compositions and methods for the treatment of cancer with methionine depletion using the disclosed proteins or nucleic acids.

    摘要翻译: 描述了与具有甲硫氨酸-γ-裂解酶活性的改进蛋白质的工程相关的方法和组合物。 例如,在某些方面,可以公开包含一个或多个氨基酸取代并能降解甲硫氨酸的修饰的胱硫醚-γ-裂解酶(CGL)。 此外,本发明的某些方面提供使用所公开的蛋白质或核酸用于用甲硫氨酸消耗治疗癌症的组合物和方法。